PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma

Published:2016-04-15 Issue:21 Volume:7 Page:30691-30701
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Kim Hyo Song¹,Lee Seung Eun²,Bae Yoon Sung³,Kim Dae Joon⁴,Lee Chang Geol⁵,Hur Jin⁶,Chung Hyunsoo⁷,Park Jun Chul⁷,Shin Sung Kwan⁷,Lee Sang Kil⁷,Lee Yong Chan⁷,Kim Hye Ryun¹,Shim Young Mog⁸,Jewell Susan S.⁹,Kim Hyunki³,Choi Yoon-La¹⁰,Cho Byoung Chul¹

Affiliation:

1. Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea

2. Department of Pathology, Konkuk University School of Medicine, Konkuk University Medical Center, Seoul, Korea

3. Department of Pathology, Yonsei University College of Medicine, Seoul, Korea

4. Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, Seoul, Korea

5. Department of Radiation Oncology, Yonsei University College of Medicine, Seoul, Korea

6. Department of Radiology, Yonsei University College of Medicine, Seoul, Korea

7. Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea

8. Department of Thoracic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

9. Abbott Molecular Laboratories, Des Plaines, IL, United States

10. Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example;Molecular Biomedicine;2024-04-15

2. The Molecular Characterization of Genetic Abnormalities in Esophageal Squamous Cell Carcinoma May Foster the Development of Targeted Therapies;Current Oncology;2023-01-03

3. Genomic Correlates of Unfavorable Outcome in Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemoradiation;Cancer Research and Treatment;2022-10-15

4. The combination of novel immune checkpoints HHLA2 and ICOSLG: A new system to predict survival and immune features in esophageal squamous cell carcinoma;Genes & Diseases;2022-03

5. Comparative genomic analysis of esophageal squamous cell carcinoma and adenocarcinoma: New opportunities towards molecularly targeted therapy;Acta Pharmaceutica Sinica B;2021-09